With the establishment of a local subsidiary of hameln pharma B.V. we are now able to support our customers directly from our dedicated Dutch operation. From July 1, 2022, the hameln pharma products can be directly ordered at hameln pharma B.V.
In taking this step, hameln pharma is seeking to intensify the collaboration with the Dutch healthcare professionals. Our high quality injection preparations, which are often used in intensive care and in the operating theatre, have been a reliable and affordable solution for Dutch hospitals for decades.